Breast Cancer News and Research

Latest Breast Cancer News and Research

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.

18 Mar 2010

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

InvestorSoup.com announces an investment report featuring Cyclacel Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

18 Mar 2010

ETP releases presentation highlights of 2010 Epilepsy Pipeline Update Conference

The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.

18 Mar 2010

iVillage launches new Health site to help women manage their health needs online

iVillage today announced the launch of its new Health site (www.ivillage.com/Health), the first women's destination on the Web that combines medical expertise and original health content with community conversations and interactive tools, to help women manage their health needs online.

18 Mar 2010

Agendia to participate in groundbreaking clinical trial for breast cancer

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

18 Mar 2010

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.

18 Mar 2010

HDC, SPM enter into development and licensing agreements with Quest Diagnostics

Health Discovery Corporation and Smart Personalized Medicine, LLC announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services.

From Quest Diagnostics 17 Mar 2010

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study’s primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.

17 Mar 2010

Clarient's Ovotax test may help improve patients’ response to taxane therapy

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.

17 Mar 2010

Circulating tumor cells could help guide treatment and improve quality of life for cancer patients

One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.

17 Mar 2010

Case management funds breast cancer screening and diagnostic services for low-income women

Case management appears to be associated with more appropriate follow-up and shorter time to diagnostic resolution among low-income women who receive an abnormal result on a mammogram, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

17 Mar 2010

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics Inc., a U.S. based genetic testing company, announced the immediate availability of its personal Genetic Health Report. This customized and innovative personal genetic health report contains information on more than 70 health conditions, including pharmacogenetics (prescription medication response), propensity for complex disease, and carrier status (pre-pregnancy health).

17 Mar 2010

Cancer news coverage should also focus on hospice and end-of-life care

Newspaper and magazine reports about cancer appear more likely to discuss aggressive treatment and survival than death, treatment failure or adverse events, and almost none mention end-of-life palliative or hospice care, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

17 Mar 2010

Cryotherapy offers potential treatment options for breast cancer patients

Interventional radiologists have opened the door to an encouraging potential future treatment for the nearly 200,000 women who are diagnosed with breast cancer in the United States each year: image-guided, multiprobe cryotherapy.

17 Mar 2010

Key cellular defect in protein synthesis can lead to cancer susceptibility

UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.

17 Mar 2010

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Orbital Therapy has completed the build of their proof-of-concept prototype for breast cancer irradiation, and demonstrated the feasibility to develop and operate an external beam radiotherapy device without the use of a heavily shielded bunker infrastructure.

16 Mar 2010

Dual role of Notch signalling pathway

Scientists headed by ICREA researcher Marco Mil-n, at the Institute for Research in Biomedicine (IRB Barcelona), reveal a surprising new function of Notch protein that contrasts with the one known to date. Found in the cell membrane, this protein activates a signalling pathway that regulates the expression of genes that make the cell divide, grow, migrate, specialise or die.

16 Mar 2010

National Breast Cancer Foundation receives over $0.5M as donation from ACE Cash Express and NetSpend

ACE Cash Express, Inc., a leading retailer of financial services, and NetSpend, a pioneer of card-based prepaid financial products to underbanked consumers, announced a donation of $502,225.67 to the National Breast Cancer Foundation in support of its mission — saving lives through early detection and providing mammograms to those in need.

16 Mar 2010

Women who undergo yearly mammography screening have lower rate of palpable tumors

New research findings published in the March issue of the Journal of the American College of Surgeons indicate that some breast cancers continue to be detected as a palpable lump rather than being found through mammographic screening.

16 Mar 2010

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

While Florida has the second highest cancer burden in the nation, the state has only one National Cancer Institute. Successfully applying for NCI designation must include a commitment for additional funding from the state. The Sylvester Comprehensive Cancer Center is launching “We Tackle Cancer” bringing attention to the critical need for a second NCI.

16 Mar 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

ETP releases presentation highlights of 2010 Epilepsy Pipeline Update Conference

iVillage launches new Health site to help women manage their health needs online

Agendia to participate in groundbreaking clinical trial for breast cancer

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

HDC, SPM enter into development and licensing agreements with Quest Diagnostics

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Clarient's Ovotax test may help improve patients’ response to taxane therapy

Circulating tumor cells could help guide treatment and improve quality of life for cancer patients

Case management funds breast cancer screening and diagnostic services for low-income women

Pathway Genomics' personal Genetic Health Report now available

Cancer news coverage should also focus on hospice and end-of-life care

Cryotherapy offers potential treatment options for breast cancer patients

Key cellular defect in protein synthesis can lead to cancer susceptibility

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Dual role of Notch signalling pathway

National Breast Cancer Foundation receives over $0.5M as donation from ACE Cash Express and NetSpend

Women who undergo yearly mammography screening have lower rate of palpable tumors

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in